ChemoCentryx Inc Stock, NASDAQ:CCXI
835 Industrial Road, Suite 600, San Carlos, California 94070
United States of America
Number of Employees: 133
ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA.